Nuveen’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Nuveen's ELV Position: Q2 2026 in Review
Nuveen increased its Elevance Health (ELV) stake by 1.5% in Q2 2026, buying an estimated $10.8M and bringing the position to 1,989,863 shares worth $770M. The position accounts for 0.18% of the portfolio, ranked #99.
Nuveen first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.61B in Q4 2022. 1,611 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Nuveen held 1,989,863 shares of Elevance Health worth $770M as of Q2 2026.
- Nuveen bought 29,158 Elevance Health shares in Q2 2026, an estimated $10.8M.
- Elevance Health made up 0.18% of Nuveen's portfolio in Q2 2026, its #99 holding.
- Nuveen first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Nuveen's Elevance Health position peaked at $1.61B in Q4 2022.
- 1,611 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.